WallStSmart

Kimberly-Clark Corporation (KMB)vsUSANA Health Sciences Inc (USNA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 1689% more annual revenue ($16.56B vs $925.26M). KMB leads profitability with a 12.8% profit margin vs 1.2%. USNA appears more attractively valued with a PEG of 0.81. KMB earns a higher WallStSmart Score of 63/100 (C+).

KMB

Buy

63

out of 100

Grade: C+

Growth: 4.7Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19

USNA

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KMBSignificantly Overvalued (-19.0%)

Margin of Safety

-19.0%

Fair Value

$90.45

Current Price

$98.43

$7.98 premium

UndervaluedFair: $90.45Overvalued
USNAUndervalued (+73.0%)

Margin of Safety

+73.0%

Fair Value

$77.70

Current Price

$19.05

$58.65 discount

UndervaluedFair: $77.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
111.7%10/10

Every $100 of equity generates 112 in profit

USNA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

KMB4 concerns · Avg: 3.3/10
PEG RatioValuation
1.994/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
21.7x2/10

Trading at 21.7x book value

USNA4 concerns · Avg: 3.3/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Market CapQuality
$360.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bull Case : USNA

The strongest argument for USNA centers on Price/Book, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : KMB

The primary concerns for KMB are PEG Ratio, Revenue Growth, Piotroski F-Score. Debt-to-equity of 4.77 is elevated, increasing financial risk.

Bear Case : USNA

The primary concerns for USNA are P/E Ratio, Market Cap, Return on Equity. Thin 1.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

USNA carries more volatility with a beta of 0.70 — expect wider price swings.

USNA is growing revenue faster at 5.9% — sustainability is the question.

KMB generates stronger free cash flow (575M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KMB scores higher overall (63/100 vs 54/100). USNA offers better value entry with a 73.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

USANA Health Sciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Want to dig deeper into these stocks?